Vivo Capital, LLC Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$905.8B
Holdings
51
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (51 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | HRMYHarmony Biosciences Holdings Inc | 3,400,261 | $150.6B | 16.63% | |
| 2 | TILInstil Bio Inc | 12,486,787 | $60.4B | 6.67% | |
| 3 | VTYXVentyx Biosciences Inc | 1,355,861 | $47.3B | 5.23% | |
| 4 | VRNAVerona Pharma PLC | 4,249,918 | $43.4B | 4.80% | |
| 5 | ALXOALX Oncology Holdings Inc | 4,220,048 | $40.4B | 4.46% | |
| 6 | TARSTarsus Pharmaceuticals Inc | 2,262,200 | $38.7B | 4.28% | |
| 7 | SVASinovac Biotech Ltd. | 5,900,000 | $38.2B | 4.21% | |
| 8 | GONGeron Corp | 15,238,095 | $35.7B | 3.94% | |
| 9 | TERNTerns Pharmaceuticals Inc | 5,899,372 | $34.7B | 3.84% | |
| 10 | VRDNViridian Therapeutics Inc | 1,660,019 | $34.0B | 3.76% | |
| 11 | COGTCogent Biosciences Inc | 1,883,941 | $28.1B | 3.10% | |
| 12 | RLMDRelmada Therapeutics Inc | 713,238 | $26.4B | 2.91% | |
| 13 | ALLKGUSDAllakos Inc | 4,120,134 | $25.2B | 2.78% | |
| 14 | AMRSEURAmyris, Inc | 7,750,828 | $22.6B | 2.50% | |
| 15 | KALVKalVista Pharmaceuticals Inc. | 1,533,559 | $22.3B | 2.46% | |
| 16 | 290AChinook Therapeutics Inc | 872,151 | $17.1B | 1.89% | |
| 17 | ASNDAscendis Pharma A/S | 146,025 | $15.1B | 1.66% | |
| 18 | AVDLAvadel Pharmaceuticals PLC | 2,937,093 | $14.7B | 1.62% | |
| 19 | VERAVera Therapeutics Inc | 666,666 | $14.2B | 1.57% | |
| 20 | ACRSAclaris Therapeutics, Inc. | 898,631 | $14.1B | 1.56% | |
| 21 | —Impel NeuroPharma Inc | 2,884,789 | $14.0B | 1.55% | |
| 22 | —Cincor Pharma Inc | 349,237 | $11.5B | 1.27% | |
| 23 | BLUBellus Health Inc | 1,017,152 | $10.7B | 1.19% | |
| 24 | LEGNLegend Biotech Corp Sponsored | 244,375 | $10.0B | 1.10% | |
| 25 | PCVXVaxcyte Inc | 404,508 | $9.7B | 1.07% | |
| 26 | ZLABZai Lab Ltd ADR | 271,528 | $9.3B | 1.03% | |
| 27 | CATBUSDAstria Therapeutics Inc | 1,000,000 | $9.0B | 1.00% | |
| 28 | MRUSMerus NV | 442,000 | $8.9B | 0.98% | |
| 29 | OPHTEURIveric Bio Inc | 483,413 | $8.7B | 0.96% | |
| 30 | IOBTIO Biotech Inc | 3,015,545 | $8.2B | 0.90% | |
| 31 | —Satsuma Pharmaceuticals Inc | 1,232,394 | $7.4B | 0.82% | |
| 32 | DYNDyne Therapeutics Inc | 577,642 | $7.3B | 0.81% | |
| 33 | WHWKAadi Bioscience Inc | 509,572 | $7.2B | 0.79% | |
| 34 | —Genetron Holdings Ltd | 8,124,174 | $6.4B | 0.70% | |
| 35 | IOVAIovance Biotherapeutics Inc | 655,057 | $6.3B | 0.69% | |
| 36 | BOLT1EURBolt Therapeutics Inc | 3,871,291 | $5.7B | 0.63% | |
| 37 | TCE2Celldex Therapeutics Inc | 198,983 | $5.6B | 0.62% | |
| 38 | —DBV Technologies SA | 2,708,875 | $4.8B | 0.53% | |
| 39 | OLMAOlema Pharmaceuticals Inc | 1,689,515 | $4.7B | 0.51% | |
| 40 | CMPXCompass Therapeutics Inc | 2,000,000 | $4.6B | 0.50% | |
| 41 | ARWRArrowhead Pharmaceuticals Inc | 137,411 | $4.5B | 0.50% | |
| 42 | ALGSAligos Therapeutics Inc | 3,547,030 | $3.9B | 0.43% | |
| 43 | GRCLGracell Biotechnologies Inc | 961,359 | $3.1B | 0.34% | |
| 44 | SERASera Prognostics Inc | 1,856,011 | $3.0B | 0.33% | |
| 45 | CDXSCodexis, Inc | 388,144 | $2.4B | 0.26% | |
| 46 | —Minerva Surgical Inc | 2,215,667 | $1.8B | 0.19% | |
| 47 | —Aslan Pharmaceuticals Ltd | 2,840,909 | $1.7B | 0.19% | |
| 48 | RZLTRezolute Inc | 489,473 | $1.3B | 0.15% | |
| 49 | FIXXEURHomology Medicines, Inc. | 370,068 | $596.0M | 0.07% | |
| 50 | DTILPrecision Biosciences Inc | 140,255 | $182.0M | 0.02% | |
| 51 | —Metacrine Inc | 146,426 | $71.0M | 0.01% |